Back to Search Start Over

Hepatitis C Market is Expected to Drive Growth at 14.2% By 2032

Source :
Financial Services Monitor Worldwide. June 14, 2023
Publication Year :
2023

Abstract

(GlobeNewswire) - Latest Research Study on Hepatitis C Market (By Drug Class: HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NSSA Inhibitors, Combination Therapy, Interferon and Antiviral, Peginterferon alfa 2a, Peginterferon [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Financial Services Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.752927740